Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Polyneuron
1262
Polyneuron
Health Care
Technology
Biotechnology
Medical
Pharmaceuticals
Swiss biotech start-up. We’re using our Antibody-Catch® technology to develop the most accurate treatment of rare autoimmune disorders.
Suggest edits
Founded
2014
Raised
$25.7M
Follow us
Companies in the same industry
SutroVax
Atlantic Healthcare plc
Rgenix
Otsuka Pharmaceutical Company Limited
myMatrixx
Euclises Pharmaceuticals
Sensulin
Ark Biosciences
Provia Laboratories
VG Life Sciences
Alexa global traffic share
Twitter followers
Overview
Funding
3
Add info
Latest funding
Show all
$22,600,000
Venture capital (Series A) - 2019
Sofinnova Partners
New Enterprise Associates
$3,109,641
Seed fund - 2018
Zürcher Kantonalbank
EVA Basel
Team Size
1–10
Employees
I work here
Location
Switzerland
Headquarters
Explore Switzerland
$22,600,000
Venture capital (Series A)
PE HUB
Swiss biotech company Polyneuron inks funding
$3,109,641
Seed fund
FinSMEs
Polyneuron Pharmaceuticals Completes CHF3.1M in Seed Financing
Health
Seed fund
startupticker
Polyneuron Pharmaceuticals closes CHF 3 Million seed financing round.ch | The Swiss Startup News channel
Health
Funding
